Royal Arc Electrodes Board of Directors

Get the latest insights into the leadership at Royal Arc Electrodes. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Bipin Sanghvi Chairman & Managing Director
Mr. Swagat Sanghvi Whole Time Director
Mr. Hardik Sanghvi WholeTime Director & CFO
Ms. Jayna Mehta Ind. Non-Executive Director
Ms. Kunal Turakhia Ind. Non-Executive Director
Mr. Rahul Vattamparambil Ind. Non-Executive Director

Royal Arc Electrodes Share price

ROYALARC

143

0.00 (0.00%)
NSE
BSE
Last updated on 4 Sep, 2025 | 10:01 IST
BUYSELL
Today's High

143.00

Today's Low

143.00

52 Week Low

114.25

52 Week High

187.80

The current prices are delayed, login to your account for live prices

Royal Arc Electrodes FAQs

The board at Royal Arc Electrodes consists of experienced professionals, including Mr. Bipin Sanghvi , Mr. Swagat Sanghvi , and others, overseeing the company’s strategic and corporate governance.

Directors at Royal Arc Electrodes are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Bipin Sanghvi is the current chairman at Royal Arc Electrodes.

Executive directors at Royal Arc Electrodes are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Royal Arc Electrodes adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Royal Arc Electrodes, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.